Identifying & Targeting Disease-Driving Cell States Using Single Cell Multiomics

Time: 8:30 am
day: Day Two


  • How can single cell multiomic analyses be leveraged to identify the best cell types and mechanistic pathways to target therapeutically?
  • Which kidney diseases and cell types are most amenable to gene therapy?
  • What are the current prospects for gene therapy in the kidney?